Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Adult-type granulosa cell tumors are molecularly characterized by a pathognomonic somatic missense point mutation 402C->G (C134W) in the transcription factor FOXL2. 28276867

2017

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE The results of this case study indicated that although FOXL2 402C > G mutation determines the development of granulosa cell tumor, PMS2 mutation may be the initial driver of carcinogenesis. 28347324

2017

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Ovarian granulosa cell tumors (GCT) are hormonally-active neoplasms characterized, in the adult-subtype, by a mutation in the FOXL2 gene (C134W). 26893359

2016

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE We also undertook FOXL2 and DICER1 mutation analysis in these cases; a somatic missense mutation in codon C134W (402C→G) of FOXL2 gene has been demonstrated in the vast majority (>95%) of ovarian adult granulosa cell tumors and somatic DICER1 mutations are found in approximately 60% of ovarian Sertoli-Leydig cell tumors. 26598979

2016

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE We propose that the 402C > G mutation in FOXL2 is critical to the development of adult granulosa cell tumor. 25297715

2014

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE To assess whether FOXL2 p.C134W mutation may play a role in the development of human ovarian tumors in the Japanese, we investigated the FOXL2 codon 134 mutation and protein expression of inhibin-α, bone morphogenetic protein 2 (BMP2) and follistatin (FST) in Japanese patients with granulosa cell tumor (GCT) of the ovary and other ovarian tumors. 24689977

2014

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors. 23372819

2013

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE A single somatic FOXL2 mutation (FOXL2(C134W)) was identified in almost all granulosa cell tumor (GCT) patients. 23567549

2013

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Recently, a single point missense mutation (C134W) was found in the FOXL2 gene in approximately 95% of adult-type granulosa cell tumors, suggesting a key role for FOXL2 in these tumors. 23875665

2013

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE The FOXL2(C134W) mutation has been identified in virtually all adult granulosa cell tumors (GCTs). 23523567

2013

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE FOXL2 mutation (402C→G) has been demonstrated in >95% of ovarian adult granulosa cell tumors, only rarely in other ovarian sex cord-stromal neoplasms, and never in ovarian fibromas. 23774170

2013

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature. 24257635

2013

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE The FOXL2 402C→G (C134W) mutation is also present in adult-type granulosa cell tumors occurring in men, although in a smaller proportion when compared with the rates reported in women. 22742556

2012

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Recently, a somatic FOXL2 mutation (p.C134W) has been reported in >95% of adult-type granulosa cell tumors. 22544055

2012

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE We found that FOXL2 (C402G) mutation was present in 19/27 (70%) of the adult type tumors but in none of the juvenile granulosa cell tumors (0/18). 21623383

2011

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Recently, FOXL2 c.402C>G, a new somatic mutation that leads to a p.C134W change, was found in the majority of adult-type ovarian granulosa cell tumors (GCTs). 21119601

2011

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Recently, FOXL2 c.402C>G, a new somatic mutation that leads to a p.C134W change, was found in the majority of adult-type ovarian granulosa cell tumors (GCTs). 21119601

2011

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors. 21293260

2011

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE FOXL2 C402G mutation detection using MALDI-TOF-MS in DNA extracted from Israeli granulosa cell tumors. 21640373

2011

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter. 21188138

2010

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Our data provide confirmation of the frequent presence of the FOXL2 C134W mutation in adult granulosa cell tumors and demonstrate that the mutation is not associated with altered FOXL2 expression. 20693978

2010

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Recently, a new mutation in FOXL2, c.402C→G leading to a p.C134W change, was reported to be found in 97% of adult-type ovarian granulosa cell tumors (GCTs) tested. 21051974

2010

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE Recently, we reported the identification of a somatic FOXL2 402C-->G mutation that is present in virtually all adult-type granulosa cell tumors, but not in a wide range of other tumor types. 19996294

2009

dbSNP: rs1057519865
rs1057519865
0.100 GeneticVariation BEFREE In addition to proving that the KGN cell line is a useful model to study A-GCTs, these data show that the c.402C>G mutation in FOXL2 is not commonly found in a wide variety of other cancers and therefore it is likely pathognomonic for A-GCTs and closely related tumors. 19956657

2009